The transition from relapsing-remitting multiple sclerosis to secondary progressive disease can be easily missed. Neurologist and clinical researcher Mark S. Freedman, MD, CSPQ, FANA, FAAN, FRCPC, discusses the assessment and management of disease progression in relapsing forms of multiple sclerosis.
